サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625440

ランセット市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、ガーゼサイズ別、年齢層別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Lancets Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Gauze Size, Age Group, End User, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ランセット市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、ガーゼサイズ別、年齢層別、エンドユーザー別、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、ランセット市場規模は2034年までに122億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

痛みを最小限に抑える技術や自動引き込み機能など、ランセット市場における技術的進歩は、患者の快適性と安全性を高めることができるため、大きな動向となっています。これらの技術革新は、採血時の不快感を軽減し、針刺し損傷や交差汚染などのリスクを最小限に抑えます。このような機能により、医療従事者や、特に糖尿病などの慢性疾患のセルフモニタリングを行っている個人の間での採用が増加しています。その結果、これらの進歩はユーザーフレンドリーな設計をサポートし、より安全で効率的な診断ツールに対する需要の高まりに合致しています。

小児医療と老人医療への注力は、これらの層特有のニーズにより、ランセット市場の重要な動向となっています。針サイズが小さく、痛みを最小限に抑える機能を備えたオーダーメードのランセットは、皮膚が薄かったり傷つきやすかったりすることが多い小児や高齢の患者にとって、快適性と安全性を確保できるように設計されています。このようなターゲットを絞ったアプローチは、ヘルスケア環境や在宅ケアでの採用率を高め、患者中心の専門的な診断ツールへの需要が高まる中、市場浸透に貢献しています。

ランセット市場レポートハイライト

タイプ別では、安全性が強化され、針刺し傷害のリスクを最小限に抑えることが重視されるようになったことから、安全ランセット分野が2024年のランセット世界市場の売上シェアをリードしました。

ランセット市場のヘモグロビン検査セグメントは、特に栄養不良が蔓延している新興国地域で貧血の有病率が上昇しており、定期的なヘモグロビン値のモニタリングが必要であることから、予測期間中に最も高いCAGRを記録すると予測されています。

2024年には、北米がランセット市場をリードしており、その背景には、強固なヘルスケアインフラ、先進診断技術の普及、政府支援、有利な償還政策があります。

アジア太平洋のランセット市場は、糖尿病有病率の上昇、ヘルスケア意識の高まり、自己モニタリング機器の使用の増加により、最も高いCAGRを記録すると予想されます。

B. Braun SE、Terumo Medical Corporation、Medline Industries, LP.、AgaMatrix、F. Hoffmann-La Roche Ltd.、ARKRAY, Inc.、Owen Mumford Ltd.、BD、Nipro Europe Group Companies、MTD Medical Technology and Devices、Astellas Pharma Inc.などが世界の主要市場企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のランセット市場の洞察

  • 年齢グループスナップショット
  • ランセット市場力学の動向
    • 促進要因と機会
      • 糖尿病の罹患率の上昇と自己モニタリングタイプの採用の増加
      • 痛みのないランセットの需要増加
    • 抑制要因と課題
      • ランセット関連の針刺し傷害感染症の発生率増加
  • PESTEL分析
  • ランセット市場の年齢層別動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のランセット市場： タイプ別

  • 主な調査結果
  • イントロダクション
  • 安全ランセット
  • 標準ランセット
  • 手動で有効化
  • 自動起動/圧力起動

第6章 世界のランセット市場：用途別

  • 主な調査結果
  • イントロダクション
  • グルコース検査
  • ヘモグロビン検査
  • 凝固検査
  • コレステロール検査
  • アレルギー検査
  • 新生児検査
  • その他の用途

第7章 世界のランセット市場： ガーゼサイズ別

  • 主な調査結果
  • イントロダクション
  • 22G以下
  • 23G-33G
  • 33G以上

第8章 世界のランセット市場：年齢層別

  • 主な調査結果
  • イントロダクション
  • 成人
  • 小児

第9章 世界のランセット市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院、診療所、外来手術センター
  • ホームケア設定
  • その他のエンドユーザー

第10章 世界のランセット市場：地域別

  • 主な調査結果
  • イントロダクション
    • ランセット市場評価：地域、2020-2034年
  • 北米
    • 北米：タイプ別、2020-2034年
    • 北米：用途別、2020-2034年
    • 北米：ガーゼサイズ別、2020-2034年
    • 北米：年齢層別、2020-2034年
    • 北米：エンドユーザー別、2020-2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020-2034年
    • 欧州：用途別、2020-2034年
    • 欧州：ガーゼサイズ別、2020-2034年
    • 欧州：年齢層別、2020-2034年
    • 欧州：エンドユーザー別、2020-2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：タイプ別、2020-2034年
    • アジア太平洋：用途別、2020-2034年
    • アジア太平洋：ガーゼサイズ別、2020-2034年
    • アジア太平洋：年齢層別、2020-2034年
    • アジア太平洋：エンドユーザー別、2020-2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020-2034年
    • 中東・アフリカ：用途別、2020-2034年
    • 中東・アフリカ：ガーゼサイズ別、2020-2034年
    • 中東・アフリカ：年齢層別、2020-2034年
    • 中東およびアフリカ：エンドユーザー別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020-2034年
    • ラテンアメリカ：用途別、2020-2034年
    • ラテンアメリカ：ガーゼサイズ別、2020-2034年
    • ラテンアメリカ：年齢層別、2020-2034年
    • ラテンアメリカ：エンドユーザー別、2020-2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • B. Braun SE
  • Terumo Medical Corporation
  • Medline Industries, LP.
  • AgaMatrix
  • F. Hoffmann-La Roche Ltd
  • ARKRAY, Inc.
  • Oro Clean Chemie AG
  • BD.
  • Nipro Europe Group Companies
  • MTD Medical Technology and Devices
  • Astellas Pharma Inc.
図表

List of Tables:

Table 1 Global Lancets Market, by Type, 2020-2034 (USD Billion)

Table 2 Global Lancets Market, by Application, 2020-2034 (USD Billion)

Table 3 Global Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 4 Global Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 5 Global Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 6 North America: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 7 North America: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 8 North America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 9 North America: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 10 North America: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 11 US: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 12 US: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 13 US: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 14 US: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 15 US: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 16 Canada: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 17 Canada: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 18 Canada: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 19 Canada: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 20 Canada: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 21 Europe: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 22 Europe: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 23 Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 24 Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 25 Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 26 UK: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 27 UK: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 28 UK: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 29 UK: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 30 UK: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 31 France: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 32 France: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 33 France: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 34 France: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 35 France: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 36 Germany: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 37 Germany: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 38 Germany: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 39 Germany: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 40 Germany: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 41 Italy: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 42 Italy: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 43 Italy: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 44 Italy: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 45 Italy: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 46 Spain: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 47 Spain: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 48 Spain: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 49 Spain: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 50 Spain: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 51 Netherlands: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 52 Netherlands: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 53 Netherlands: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 54 Netherlands: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 55 Netherlands: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 56 Russia: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 57 Russia: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 58 Russia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 59 Russia: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 60 Russia: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 61 Rest of Europe: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 62 Rest of Europe: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 63 Rest of Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 64 Rest of Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 65 Rest of Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 66 Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 67 Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 68 Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 69 Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 70 Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 71 China: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 72 China: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 73 China: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 74 China: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 75 China: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 76 India: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 77 India: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 78 India: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 79 India: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 80 India: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 81 Malaysia: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 82 Malaysia: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 83 Malaysia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 84 Malaysia: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 85 Malaysia: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 86 Japan: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 87 Japan: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 88 Japan: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 89 Japan: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 90 Japan: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 91 Indonesia: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 92 Indonesia: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 93 Indonesia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 94 Indonesia: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 95 Indonesia: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 96 South Korea: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 97 South Korea: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 98 South Korea: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 99 South Korea: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 100 South Korea: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 101 Australia: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 102 Australia: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 103 Australia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 104 Australia: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 105 Australia: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 106 Rest of Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 107 Rest of Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 108 Rest of Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 109 Rest of Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 110 Rest of Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 111 Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 112 Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 113 Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 114 Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 115 Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 116 Saudi Arabia: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 117 Saudi Arabia: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 118 Saudi Arabia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 119 Saudi Arabia: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 120 Saudi Arabia: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 121 UAE: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 122 UAE: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 123 UAE: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 124 UAE: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 125 UAE: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 126 Israel: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 127 Israel: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 128 Israel: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 129 Israel: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 130 Israel: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 131 South Africa: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 132 South Africa: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 133 South Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 134 South Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 135 South Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 136 Rest of Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 137 Rest of Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 138 Rest of Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 139 Rest of Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 140 Rest of Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 141 Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 142 Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 143 Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 144 Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 145 Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 146 Mexico: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 147 Mexico: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 148 Mexico: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 149 Mexico: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 150 Mexico: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 151 Brazil: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 152 Brazil: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 153 Brazil: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 154 Brazil: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 155 Brazil: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 156 Argentina: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 157 Argentina: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 158 Argentina: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 159 Argentina: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 160 Argentina: Lancets Market, by End Users, 2020-2034 (USD Billion)

Table 161 Rest of Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)

Table 162 Rest of Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)

Table 163 Rest of Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)

Table 164 Rest of Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)

Table 165 Rest of Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Lancets Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global Lancets Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global Lancets Market, by Application, 2024 & 2034 (USD Billion)

Figure 10. Market by Gauze Size

Figure 11. Global Lancets Market, by Gauze Size, 2024 & 2034 (USD Billion)

Figure 12. Market by Age Group

Figure 13. Global Lancets Market, by Age Group, 2024 & 2034 (USD Billion)

Figure 14. Market by End Users

Figure 15. Global Lancets Market, by End Users, 2024 & 2034 (USD Billion)

目次
Product Code: PM5315

The lancets market size is expected to reach USD 12.23 billion by 2034, according to a new study by Polaris Market Research. The report "Lancets Market Share, Size, Trends, Industry Analysis Report: By Type, Application, Gauze Size (22G and Below, 23G-33G, and Above 33G), Age Group, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technological advancements in the lancets market, such as pain-minimizing technologies and automatic retraction features, have become a major trend due to their ability to enhance patient comfort and safety. These innovations reduce discomfort during blood sampling and minimize risks such as needle stick injuries and cross-contamination. Such features have led to increased adoption among healthcare professionals and individuals performing self-monitoring, particularly for chronic conditions such as diabetes. As a result, these advancements support user-friendly designs and align with the growing demand for safer and more efficient diagnostic tools.

Focusing on pediatric and geriatric care has become a significant lancets market trend due to the unique needs of the demographics. Tailored lancets with smaller needle sizes and pain-minimizing features are designed to ensure comfort and safety for children and elderly patients, who often have thinner or more fragile skin. This targeted approach increases adoption rates in healthcare settings and at-home care, contributing to market penetration as demand for specialized, patient-centric diagnostic tools grows.

Lancets Market Report Highlights

In terms of type, the safety lancets segment led the global lancets market revenue share in 2024 due to their enhanced safety features and the growing emphasis on minimizing the risk of needle-stick injuries.

The hemoglobin testing segment of the lancets market is anticipated to register the highest CAGR during the forecast period due to the rising prevalence of anemia, particularly in developing regions where malnutrition is more widespread, necessitating regular hemoglobin level monitoring.

In 2024, North America led the lancets market, driven by its robust healthcare infrastructure, widespread adoption of advanced diagnostic technologies, government support, and favorable reimbursement policies.

The Asia Pacific lancets market is expected to record the highest CAGR due to the rising prevalence of diabetes, increasing healthcare awareness, and growing use of self-monitoring devices.

B. Braun SE; Terumo Medical Corporation; Medline Industries, LP.; AgaMatrix; F. Hoffmann-La Roche Ltd; ARKRAY, Inc.; Owen Mumford Ltd.; BD; Nipro Europe Group Companies; MTD Medical Technology and Devices; and Astellas Pharma Inc. are a few global key market players.

Polaris Market Research has segmented the lancets market report on the basis of type, application, gauze size, age group, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Safety Lancets
  • Standard Lancets
  • Manually Activated
  • Push Button Lancets
  • Side Button Lancets
  • Automatically Activated/Pressure Activated

By Application Outlook (Revenue, USD Billion, 2020-2034)

  • Glucose Testing
  • Hemoglobin Testing
  • Coagulation Testing
  • Cholesterol Testing
  • Allergy Testing
  • Neonatal Testing
  • Other Applications

By Gauze Size Outlook (Revenue, USD Billion, 2020-2034)

  • 22G and Below
  • 23G-33G
  • Above 33G

By Age Group Outlook (Revenue, USD Billion, 2020-2034)

  • Adult
  • Pediatrics
  • By End User (Revenue, USD Billion, 2020-2034)
  • Hospitals, Clinics, and Ambulatory Surgery Centers
  • Homecare Settings
  • Other end users

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lancets Market Insights

  • 4.1. Lancets Market - Age Group Snapshot
  • 4.2. Lancets Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Diabetes and Increasing Adoption of Self-Monitoring Types
      • 4.2.1.2. Increasing Demand for Painless Lancets
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Increasing Incidence of Lancet-related Needle stick Injuries Infections
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lancets Market Age Group Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lancets Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lancets Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Safety Lancets
    • 5.3.1. Global Lancets Market, by Safety Lancets, by Region, 2020-2034 (USD Billion)
  • 5.4. Standard Lancets
    • 5.4.1. Global Lancets Market, by Standard Lancets, by Region, 2020-2034 (USD Billion)
  • 5.5. Manually Activated
    • 5.5.1. Global Lancets Market, by Manually Activated, by Region, 2020-2034 (USD Billion)
    • 5.5.2. Push Button Lancets
      • 5.5.2.1. Global Lancets Market, by Push Button Lancets, by Region, 2020-2034 (USD Billion)
    • 5.5.3. Side Button Lancets
      • 5.5.3.1. Global Lancets Market, by Side Button Lancets, by Region, 2020-2034 (USD Billion)
  • 5.6. Automatically activated/Pressure activated
    • 5.6.1. Global Lancets Market, by Automatically activated/Pressure activated, by Region, 2020-2034 (USD Billion)

6. Global Lancets Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lancets Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Glucose Testing
    • 6.3.1. Global Lancets Market, by Glucose Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Hemoglobin Testing
    • 6.4.1. Global Lancets Market, by Hemoglobin Testing, by Region, 2020-2034 (USD Billion)
  • 6.5. Coagulation Testing
    • 6.5.1. Global Lancets Market, by Coagulation Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Cholesterol Testing
    • 6.6.1. Global Lancets Market, by Cholesterol Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Allergy Testing
    • 6.7.1. Global Lancets Market, by Allergy Testing, by Region, 2020-2034 (USD Billion)
  • 6.8. Neonatal Testing
    • 6.8.1. Global Lancets Market, by Neonatal Testing, by Region, 2020-2034 (USD Billion)
  • 6.9. Other Applications
    • 6.9.1. Global Lancets Market, by Other Applications, by Region, 2020-2034 (USD Billion)

7. Global Lancets Market, by Gauze Size

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
  • 7.3. 22G and Below
    • 7.3.1. Global Lancets Market, by 22G and Below, by Region, 2020-2034 (USD Billion)
  • 7.4. 23G-33G
    • 7.4.1. Global Lancets Market, by 23G-33G, by Region, 2020-2034 (USD Billion)
  • 7.5. Above 33G
    • 7.5.1. Global Lancets Market, by Above 33G, by Region, 2020-2034 (USD Billion)

8. Global Lancets Market, by Age Group

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Lancets Market, by Age Group, 2020-2034 (USD Billion)
  • 8.3. Adult
    • 8.3.1. Global Lancets Market, by Adult, by Region, 2020-2034 (USD Billion)
  • 8.4. Pediatrics
    • 8.4.1. Global Lancets Market, by Pediatrics, by Region, 2020-2034 (USD Billion)

9. Global Lancets Market, by End Users

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 9.3. Hospitals, Clinics and Ambulatory Surgery Centers
    • 9.3.1. Global Lancets Market, by Hospitals, Clinics and Ambulatory Surgery Centers, by Region, 2020-2034 (USD Billion)
  • 9.4. Homecare Settings
    • 9.4.1. Global Lancets Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)
  • 9.5. Other end users
    • 9.5.1. Global Lancets Market, by Other end users, by Region, 2020-2034 (USD Billion)

10. Global Lancets Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Lancets Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Lancets Market - North America
    • 10.3.1. North America: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.3.3. North America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.3.4. North America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.3.5. North America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.6. North America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.7. Lancets Market - US
      • 10.3.7.1. US: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. US: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.3. US: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.3.7.4. US: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.3.7.5. US: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.8. Lancets Market - Canada
      • 10.3.8.1. Canada: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.4. Lancets Market - Europe
    • 10.4.1. Europe: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.6. Lancets Market - UK
      • 10.4.6.1. UK: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.7. Lancets Market - France
      • 10.4.7.1. France: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.8. Lancets Market - Germany
      • 10.4.8.1. Germany: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.9. Lancets Market - Italy
      • 10.4.9.1. Italy: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.10. Lancets Market - Spain
      • 10.4.10.1. Spain: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.11. Lancets Market - Netherlands
      • 10.4.11.1. Netherlands: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.12. Lancets Market - Russia
      • 10.4.12.1. Russia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.13. Lancets Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.5. Lancets Market - Asia Pacific
    • 10.5.1. Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.6. Lancets Market - China
      • 10.5.6.1. China: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.7. Lancets Market - India
      • 10.5.7.1. India: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.8. Lancets Market - Malaysia
      • 10.5.8.1. Malaysia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.9. Lancets Market - Japan
      • 10.5.9.1. Japan: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.10. Lancets Market - Indonesia
      • 10.5.10.1. Indonesia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.11. Lancets Market - South Korea
      • 10.5.11.1. South Korea: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.12. Lancets Market - Australia
      • 10.5.12.1. Australia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.13. Lancets Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.6. Lancets Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.6. Lancets Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.7. Lancets Market - UAE
      • 10.6.7.1. UAE: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.8. Lancets Market - Israel
      • 10.6.8.1. Israel: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.9. Lancets Market - South Africa
      • 10.6.9.1. South Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.10. Lancets Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.7. Lancets Market - Latin America
    • 10.7.1. Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.6. Lancets Market - Mexico
      • 10.7.6.1. Mexico: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.7. Lancets Market - Brazil
      • 10.7.7.1. Brazil: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.8. Lancets Market - Argentina
      • 10.7.8.1. Argentina: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.9. Lancets Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. B. Braun SE
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Terumo Medical Corporation
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Medline Industries, LP.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. AgaMatrix
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. F. Hoffmann-La Roche Ltd
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. ARKRAY, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Oro Clean Chemie AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. BD.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Nipro Europe Group Companies
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. MTD Medical Technology and Devices
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Astellas Pharma Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development